Exploring the Significance of p۵۳ Gene in Lung Cancer: Etiological Factors, Clinical Implications, and Therapeutic Approaches

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 100

فایل این مقاله در 15 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_MCIJO-7-4_001

تاریخ نمایه سازی: 10 شهریور 1403

چکیده مقاله:

Lung cancer is a type of cancer that originates in the lungs, which are responsible for breathing. The p۵۳ gene plays a critical crucial role in inhibiting cancer progression by regulating cell growth, DNA repair, and apoptosis. In lung cancer, p۵۳ mutations are common and associated with aggressive tumor growth, chemotherapy resistance, and poor survival outcomes. This article reviews explores the etiological factors and therapeutic approaches related to p۵۳ dysregulation in lung cancer.  Early detection is key for improving treatment response success and patient survival. Research on p۵۳ mutations in lung cancer has provided valuable insights into the molecular mechanisms driving tumorigenesis and treatment response. Targeted therapies for the treatment of lung cancer treatment have shown immense potential by targeting the p۵۳ pathway. It is critical to understand the clinical significance of p۵۳ mutations as they play a crucial role in determining the success of treatment and the patient's prognosis. Personalized treatment approaches must be considered, and future research should focus on developing new targeted therapies, expanding knowledge of p۵۳ mutations in other cancer types, and improving diagnostic tools for to identifying p۵۳ mutations in lung cancer patients. By investing in these areas, we can pave the way for more effective and personalized treatment for lung cancer patients.

کلیدواژه ها:

نویسندگان

Shahram Sadeghvand

Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Hadi Nasiri

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Ali Sadighi

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Javad Ahmadian Heris

Department of Allergy and Clinical Immunology, Pediatric Hospital, Tabriz University of Medical Sciences, Tabriz, Iran

Parviz Shahabi

Department of Medical Physiology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Navid Shomali

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Reza Mohammadi Nasab

Department of History of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Sajjad Hejazi

Department of Anatomy, School of Veterinary Medicine, Near East University, Nicosia, North Cyprus

Ali Bahadori

Department of Medical Microbiology, Sarab University of Medical Sciences, Sarab, Iran

Morteza Akbari

Department of Medical Biotechnology, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Tao M-H. Epidemiology of lung cancer. Lung Cancer and Imaging. ...
  • Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung ...
  • Bade BC, Cruz CSD. Lung cancer ۲۰۲۰: epidemiology, etiology, and ...
  • Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. ...
  • Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung ...
  • Corrales L, Rosell R, Cardona AF, Martin C, Zatarain-Barrón ZL, ...
  • Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, ...
  • Gupta A, Shah K, Oza MJ, Behl T. Reactivation of ...
  • Duffy MJ, Synnott NC, Crown J. Mutant p۵۳ as a ...
  • Zhang C, Liu J, Xu D, Zhang T, Hu W, ...
  • Levine AJ. P۵۳ and the immune response: ۴۰ years of ...
  • Xu, F., Lin, H., He, P., He, L., Chen, J., ...
  • Tung M-C, Lin P-L, Wang Y-C, He T-Y, Lee M-C, ...
  • Zhou Y, Höti N, Ao M, Zhang Z, Zhu H, ...
  • Hao X-l, Han F, Zhang N, Chen H-q, Jiang X, ...
  • Zhang T, Li Y, Zhu R, Song P, Wei Y, ...
  • Duffy MJ, Synnott NC, O’Grady S, Crown J, editors. Targeting ...
  • Nakamura M, Obata T, Daikoku T, Fujiwara H. The association ...
  • Boutelle AM, Attardi LD. p۵۳ and tumor suppression: it takes ...
  • Hassin O, Oren M. Drugging p۵۳ in cancer: one protein, ...
  • Bourdon J-C. p۵۳ Family isoforms. Current pharmaceutical biotechnology. ۲۰۰۷;۸(۶):۳۳۲-۶ ...
  • Tsao M-S, Aviel-Ronen S, Ding K, Lau D, Liu N, ...
  • Ahrendt SA, Hu Y, Buta M, McDermott MP, Benoit N, ...
  • Wudu M, Ren H, Hui L, Jiang J, Zhang S, ...
  • Mogi A, Kuwano H. TP۵۳ mutations in nonsmall cell lung ...
  • Mathe E, Olivier M, Kato S, Ishioka C, Hainaut P, ...
  • Floquet C, Deforges J, Rousset J-P, Bidou L. Rescue of ...
  • Tong DR, Zhou W, Katz C, Regunath K, Venkatesh D, ...
  • Holmila R, Fouquet C, Cadranel J, Zalcman G, Soussi T. ...
  • Kastenhuber ER, Lowe SW. Putting p۵۳ in context. Cell. ۲۰۱۷;۱۷۰(۶):۱۰۶۲-۷۸ ...
  • Cooper WA, Lam DC, O’Toole SA, Minna JD. Molecular biology ...
  • Viktorsson K, De Petris L, Lewensohn R. The role of ...
  • Alvarado-Ortiz E, de la Cruz-López KG, Becerril-Rico J, Sarabia-Sánchez MA, ...
  • Smith, A. G., & Macleod, K. F. (۲۰۱۹). Autophagy, cancer ...
  • Lee, S. B., Lee, S., Park, J. Y., Lee, S. ...
  • Murai, K., Skrupskelyte, G., Piedrafita, G., Hall, M., Kostiou, V., ...
  • Wang, H. Q., Mulford, I. J., Sharp, F., Liang, J., ...
  • Wang, X., & Sun, Q. (۲۰۱۷). TP۵۳ mutations, expression and ...
  • Esteban-Burgos, L., Wang, H., Nieto, P., Zheng, J., Blanco-Aparicio, C., ...
  • Brown, K. R., Mair, B., Soste, M., & Moffat, J. ...
  • García‐Cano, J., Sánchez‐Tena, S., Sala‐Gaston, J., Figueras, A., Viñals, F., ...
  • Aisner, D. L., Sholl, L. M., Berry, L. D., Rossi, ...
  • Martinez-Useros, J., Martin-Galan, M., Florez-Cespedes, M., & Garcia-Foncillas, J. (۲۰۲۱). ...
  • Marei HE, Althani A, Afifi N, Hasan A, Caceci T, ...
  • Canale M, Andrikou K, Priano I, Cravero P, Pasini L, ...
  • Zienolddiny S, Ryberg D, Arab M, Skaug V, Haugen A. ...
  • Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, ...
  • Chen L, Liu S, Tao Y. Regulating tumor suppressor genes: ...
  • Zhu J, Singh M, Selivanova G, Peuget S. Pifithrin-α alters ...
  • Chen C-Y, Hsu Y-L, Tsai Y-C, Kuo P-L. Kotomolide A ...
  • Nuciforo PG, Luise C, Capra M, Pelosi G, d'Adda di ...
  • Nichols CA, Gibson WJ, Brown MS, Kosmicki JA, Busanovich JP, ...
  • Marsit CJ, Hasegawa M, Hirao T, Kim D-H, Aldape K, ...
  • Nishisaka T, Takeshima Y, Inai K. Evaluation of p۵۳ gene ...
  • Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, ...
  • Deben C, Deschoolmeester V, Lardon F, Rolfo C, Pauwels P. ...
  • Fortunato O, Boeri M, Moro M, Verri C, Mensah M, ...
  • Mounawar M, Mukeria A, Le Calvez F, Hung RJ, Renard ...
  • Xing Y, Liu Y, Liu T, Meng Q, Lu H, ...
  • Xu Z, Wu W, Yan H, Hu Y, He Q, ...
  • Ning Y, Hui N, Qing B, Zhuo Y, Sun W, ...
  • Putri HE, Nutho B, Rungrotmongkol T, Sritularak B, Vinayanuwattikun C, ...
  • Cheng F, Dou J, Zhang Y, Wang X, Wei H, ...
  • Jo S-K, Hong J-Y, Park HJ, Lee SK. Anticancer activity ...
  • Nian W, Ao X, Wu Y, Huang Y, Shao J, ...
  • Storozhuk Y, Sanli T, Hopmans SN, Schultz C, Farrell T, ...
  • Campling BG, El-Deiry WS. Clinical implications of p۵۳ mutations in ...
  • Scoccianti C, Vesin A, Martel G, Olivier M, Brambilla E, ...
  • Jiao X-D, Qin B-D, You P, Cai J, Zang Y-S. ...
  • Dey A, Wong E, Bist P, Tergaonkar V, Lane D. ...
  • KUMAR S, MOHAN A, GULERIA R. Prognostic implications of circulating ...
  • Endoh H, Yatabe Y, Shimizu S, Tajima K, Kuwano H, ...
  • Yang S, Che SP, Kurywchak P, Tavormina JL, Gansmo LB, ...
  • Horio Y, Takahashi T, Kuroishi T, Hibi K, Suyama M, ...
  • Mitsudomi T, Hamajima N, Ogawa M, Takahashi T. Prognostic significance ...
  • Schiller JH, Adak S, Feins RH, Keller SM, Fry WA, ...
  • Qin K, Hou H, Liang Y, Zhang X. Prognostic value ...
  • Wang F, Zhao N, Gao G, Deng H-B, Wang Z-H, ...
  • Ciancio N, Galasso MG, Campisi R, Bivona L, Migliore M, ...
  • Chang Y-L, Wu C-T, Lin S-C, Hsiao C-F, Jou Y-S, ...
  • Ma X, Le Teuff G, Lacas B, Tsao MS, Graziano ...
  • Nishizaki M, Meyn RE, Levy LB, Atkinson EN, White RA, ...
  • Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, ...
  • Turrell FK, Kerr EM, Gao M, Thorpe H, Doherty GJ, ...
  • Goldstein I, Marcel V, Olivier M, Oren M, Rotter V, ...
  • Schneider BJ, Kalemkerian GP. Personalized therapy of small cell lung ...
  • Salgia R, Hensing T, Campbell N, Salama AK, Maitland M, ...
  • Yang C, Huang X, Li Y, Chen J, Lv Y, ...
  • Chandrasekar D, Tribett E, Ramchandran K. Integrated palliative care and ...
  • Patel S, Player MR. Small-molecule inhibitors of the p۵۳-HDM۲ interaction ...
  • Celegato M, Messa L, Goracci L, Mercorelli B, Bertagnin C, ...
  • Liu, Y., Wang, X., Wang, G., Yang, Y., Yuan, Y., ...
  • Cao, H., Chen, X., Wang, Z., Wang, L., Xia, Q., ...
  • Munagala R, Aqil F, Jeyabalan J, Kandimalla R, Wallen M, ...
  • Hasbullah HH, Musa M. Gene therapy targeting p۵۳ and KRAS ...
  • Wang, D. C., Wang, W., Zhu, B., & Wang, X. ...
  • Chen, S. Y., Tsuneyama, K., Yen, M. H., Lee, J. ...
  • Kasala ER, Bodduluru LN, Barua CC, Sriram CS, Gogoi R. ...
  • Freedman AN, Michalek AM, Marshall JR, Mettlin CJ, Petrelli NJ, ...
  • Castejón, M., Plaza, A., Martinez-Romero, J., Fernandez-Marcos, P. J., de ...
  • Xue W, Dahlman JE, Tammela T, Khan OF, Sood S, ...
  • Patel, S., Petty, W. J., & Sands, J. M. (۲۰۲۱). ...
  • Saleh, M. N., Patel, M. R., Bauer, T. M., Goel, ...
  • Açıkalın Çoşkun K, Tutar M, Al M, Gök Yurttaş A, ...
  • Filipczak PT, Leng S, Tellez CS, Do KC, Grimes MJ, ...
  • Chou C-W, Lin C-H, Hsiao T-H, Lo C-C, Hsieh C-Y, ...
  • Zhu G, Pan C, Bei J-X, Li B, Liang C, ...
  • Santarpia M, Ciappina G, Spagnolo CC, Squeri A, Passalacqua MI, ...
  • Sun H, Liu S-Y, Zhou J-Y, Xu J-T, Zhang H-K, ...
  • Wadowska K, Bil-Lula I, Trembecki Ł, Śliwińska-Mossoń M. Genetic markers ...
  • نمایش کامل مراجع